Madrigal Pharmaceuticals (MDGL) Other financing activities (2022 - 2025)
Madrigal Pharmaceuticals (MDGL) reported Other financing activities of $983000.0 for Q4 2025, up 1210.67% quarter-over-quarter from $75000.0 in Q3 2023.
Madrigal Pharmaceuticals (MDGL) Other financing activities (2022 - 2025) Analysis & Trends
Madrigal Pharmaceuticals (MDGL) has 3 years of Other financing activities data on file, last reported at $983000.0 in Q4 2025.
- Other financing activities for Q4 2025 came in at $983000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $983000.0 (changed N/A YoY), and the FY2025 annual result was $10.4 million, changed N/A from the prior year.
- Other financing activities advanced to $983000.0 in Q4 2025 per MDGL's latest filing, from $75000.0 in the prior quarter.
- Over five years, Other financing activities peaked at $983000.0 in Q4 2025 and troughed at $75000.0 in Q2 2023.
- A 3-year average of $446400.0 and a median of $213000.0 in 2023 frame the typical range for Other financing activities.
- On a YoY basis, Other financing activities climbed as much as 91.53% in 2023 and fell as far as 91.53% in 2023.
- A 3-year view of Other financing activities shows it stood at $886000.0 in 2022, then plunged by 91.53% to $75000.0 in 2023, then surged by 1210.67% to $983000.0 in 2025.
- Business Quant data shows MDGL's Other financing activities at $983000.0 in Q4 2025, $75000.0 in Q3 2023, and $75000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Madrigal Pharmaceuticals | 14.67 Bn | 14.44 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 983,000.00 |
| Dec 31, 2025 | 983,000.00 |
| Sep 30, 2023 | 75,000.00 |
| Sep 30, 2023 | 75,000.00 |
| Jun 30, 2023 | 75,000.00 |
| Jun 30, 2023 | 75,000.00 |
| Mar 31, 2023 | 213,000.00 |
| Mar 31, 2023 | 213,000.00 |
| Jun 30, 2022 | 886,000.00 |
| Jun 30, 2022 | 886,000.00 |